Nalaganje...
Current modalities in cancer immunotherapy: immunomodulatory antibodies, CARs and vaccines
Successes of immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cell therapy in curing patients with otherwise lethal cancers have validated immunotherapy as a treatment for cancer and have inspired excitement for its broader potential. Most promising is the ability of each ap...
Shranjeno v:
| izdano v: | Pharmacol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600680/ https://ncbi.nlm.nih.gov/pubmed/28322974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2017.03.008 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|